Cincinnati is Home to a Robust Life Sciences Ecosystem

Earlier this month startup CinCor achieved a milestone in Cincinnati – the largest Series A financing raised by a company in the city.

CinCor raised the $50 million to support the development of a therapy aimed at the treatment-resistant hypertension and primary aldosteronism, a hormonal disorder that can lead to high blood pressure. CinCor acquired the rights to the medication from Swiss pharma giant Roche. CinCor’s financial bounty helps shine a light on the life sciences region in and around Cincinnati.